Settling the “score” with liver cancer

por Koh, Christopher, Liang, T. Jake
Publicado em 2008

Letter: need to re-evaluate noninvasive markers for staging fibrosis in chronic delta hepatitis - Authors' Reply

por Takyar, Varun, Koh, Christopher
Publicado no Aliment Pharmacol Ther (2017)

Letter: Complications of percutaneous liver biopsy with Klatskin needles - a 36-year single-center experience: methodological issue. Authors’ Reply

por Takyar, Varun, Koh, Christopher
Publicado no Aliment Pharmacol Ther (2017)

What is the future of ribavirin therapy for hepatitis C?

por Koh, Christopher, Liang, T. Jake
Publicado no Antiviral Res (2014)

Approach to the diagnosis of portal hypertension

por Koh, Christopher, Heller, Theo
Publicado no Clin Liver Dis (Hoboken) (2012)

Enfoque diagnóstico de la hipertensión portal

por Koh, Christopher, Heller, Theo
Publicado no Clin Liver Dis (Hoboken) (2013)

Coronavirus Disease-19 Has Come Home to Roost in Gastroenterology

por Koh, Christopher, Liang, T. Jake
Publicado no Gastroenterology (2020)

Clinical Challenges and Images in GI: Glowing In The Dark: Not Always A Bad Thing

por Sakiani, Sasan, Koh, Christopher, Heller, Theo
Publicado em 2010

Understanding the Presence of False-Positive Antibodies in Acute Hepatitis

por Sakiani, Sasan, Koh, Christopher, Heller, Theo
Publicado no J Infect Dis (2014)

Reply to Tennant and Post

por Sakiani, Sasan, Koh, Christopher, Heller, Theo
Publicado no J Infect Dis (2016)

Letter: Changes in FIB-4 cut-off points for viral hepatitis - Authors’ Reply

por Surana, Pallavi, Takyar, Varun, Koh, Christopher
Publicado no Aliment Pharmacol Ther (2017)

Reply: Cystic Fibrosis Liver Disease in Adults: limits of non-invasive tests of fibrosis

por Koh, Christopher, Sakiani, Sasan, Heller, Theo
Publicado no Hepatology (2018)

Pathogenesis of and New Therapies for Hepatitis D

por Koh, Christopher, Heller, Theo, Glenn, Jeffrey S.
Publicado no Gastroenterology (2018)

Noncirrhotic portal hypertension: An overview

por Etzion, Ohad, Koh, Christopher, Heller, Theo
Publicado no Clin Liver Dis (Hoboken) (2015)

Chronic hepatitis delta: A state-of-the-art review and new therapies

por Gilman, Christy, Heller, Theo, Koh, Christopher
Publicado no World J Gastroenterol (2019)

Liver Disease in Patients with Cystic Fibrosis

por Kamal, Natasha, Surana, Pallavi, Koh, Christopher
Publicado no Curr Opin Gastroenterol (2018)

Clinical Challenges and Images in GI: Black smoke arising in duodenum after liver biopsy – What does the smoke signal mean?

por Chitsaz, Ehsan, Krishnasammy, Venkatesh, Koh, Christopher
Publicado no Gastroenterology (2020)

Don’t Forget To Polarize Your Lenses!

por Koh, Christopher, Kleiner, David E., Heller, Theo
Publicado em 2009

The Many Faces of Positive Hepatitis B Surface Antigen

por Tang, Derek M., Heller, Theo, Koh, Christopher
Publicado no Hepatology (2016)

HBV/HDV Coinfection: Emerging therapeutic options for a challenging disease.

por Koh, Christopher, Da, Ben L., Glenn, Jeffrey S.
Publicado no Clin Liver Dis (2019)